THIS IS THE FACE OF ADVANCED BCC TODAY

Advanced basal cell carcinoma can invade surrounding soft tissue, cartilage, and bone in locations such as the ear. Excision may mean complete removal of the visible part of the ear.[1-3] When the BCC is invasive and disfigurement may be unavoidable...


WHAT'S NEXT FOR THESE PATIENTS?

For More Information: Register Now
http://interactive.genentech.com/content/emedia/view/SkinCancer-Opt-In.view.html?cid=3002HHHSDS

Genentech is investigating the molecular basis of skin cancers such as advanced BCC.

Register now for more information.
http://interactive.genentech.com/content/emedia/view/SkinCancer-Opt-In.view.html?cid=3002HHHSDS

References: 1. Jarell AD, Mully TW. Basal cell carcinoma on the ear is more likely to be of an aggressive phenotype in both men and women. J Am Acad Dermatol. In press. 2. Habif TP. Premalignant and malignant nonmelanoma skin tumors. In: Habif TP. Clinical Dermatology. 5th ed. St Louis, MO: Mosby Elsevier; 2009. 3. Parizel PM, Dirix L, Van den Weyngaert D, et al. Deep cerebral invasion by basal cell carcinoma of the scalp. Neuroradiology. 1996;38:575-577.

To view the Privacy Policy, please copy and paste the URL below into a Web browser:
http://www.gene.com/gene/privacy.html?cid=3002HHHSDS

To view the Terms and Conditions, please copy and paste the URL below into a Web browser:
http://www.gene.com/gene/terms.html?cid=3002HHHSDS

To contact Genentech[R], please copy and paste the URL below into a Web browser:
http://www.gene.com/gene/contact/san-francisco.html?cid=3002HHHSDS

To visit Genentech[R], please copy and paste the URL below into a Web browser:
http://www.gene.com/gene/index.jsp?cid=3002HHHSDS

This e-mail is intended for U.S. healthcare professionals only.

Genentech USA, Inc.
1 DNA Way
South San Francisco, CA
94080-4990

Copyright 2011 Genentech USA, Inc. All rights reserved.

To unsubscribe from the Genentech mailing list, please copy and paste the URL below into a Web browser:
http://interactive.genentech.com/content/emedia/view/SkinCancer-Opt-Out.view.html?cid=3002HHHSDS

HED0000751000